E-LIB Suche - Ergebnisse für: Gordon, Leo I

1

Lisocabtagene Maraleucel (liso-cel) As Second-Line Therapy ..:

Hoda, Daanish ; Sehgal, Alison ; Riedell, Peter A....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S202 , 2024

Link: https://doi.org/10.1016/..

2

Subsequent malignant neoplasms in patients previously treat..:

Melody, Megan ; Epperla, Narendranath ; Shouse, Geoffrey...
Blood Advances. 8 (2024) 10 - p. 2327-2331 , 2024

Link: https://doi.org/10.1182/..

3

Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S14 , 2024

Link: https://doi.org/10.1016/..

4

Sequencing of cellular therapy and bispecific antibodies fo..:

Melody, Megan ; Gordon, Leo I.
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

Outcomes of patients with secondary central nervous system ..:

Epperla, Narendranath ; Feng, Lei ; Shah, Nirav N....
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

Humoral Immunity After COVID-19 Vaccination in Chronic Lymp..:

Doukas, Peter G ; St. Pierre, Frederique ; Karmali, Reem...
The Oncologist. 28 (2023) 10 - p. e930-e941 , 2023

Link: https://doi.org/10.1093/..

7

Ibrutinib Maintenance Following Frontline Treatment in Pati..:

Karmali, Reem ; Abramson, Jeremy S ; Stephens, Deborah M....
Blood Advances. , 2023

Link: https://doi.org/10.1182/..

8

Peri–CAR-T practice patterns and survival predictors for al..:

Zurko, Joanna ; Nizamuddin, Imran ; Epperla, Narendranath...
Blood Advances. 7 (2023) 12 - p. 2657-2669 , 2023

Link: https://doi.org/10.1182/..

9

Sequential pembrolizumab and AVD are highly effective at an..:

Allen, Pamela B. ; Lu, Xinyan ; Chen, Qing...
Blood Advances. 7 (2023) 12 - p. 2670-2676 , 2023

Link: https://doi.org/10.1182/..

10

Multicenter phase 2 study of romidepsin plus lenalidomide f..:

Ruan, Jia ; Zain, Jasmine ; Palmer, Brett...
Blood Advances. 7 (2023) 19 - p. 5771-5779 , 2023

Link: https://doi.org/10.1182/..

11

MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Pri..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S458 , 2023

Link: https://doi.org/10.1016/..

12

Is Language a Barrier to Assessment of Neurotoxicity Associ..:

Melody, Megan ; Burkart, Madelyn ; Karmali, Reem...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S353-S354 , 2023

Link: https://doi.org/10.1016/..

13

Single Institution Review of Anakinra for the Management of..:

Melody, Megan ; Karmali, Reem ; Winter, Jane...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S195 , 2023

Link: https://doi.org/10.1016/..

14

Lisocabtagene maraleucel for second-line relapsed or refrac..:

Gordon, Leo I. ; Liu, Fei Fei ; Braverman, Julia...
Haematologica. 109 (2023) 3 - p. 857-866 , 2023

Link: https://doi.org/10.3324/..

15

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibitio..:

Gordon, Leo I. ; Karmali, Reem ; Kaplan, Jason B....
Oncotarget. 14 (2023) 1 - p. 57-70 , 2023

Link: https://doi.org/10.18632..